TIMP4
Basic information
Region (hg38): 3:12153068-12158912
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TIMP4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 22 | 23 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 2 | 1 |
Variants in TIMP4
This is a list of pathogenic ClinVar variants found in the TIMP4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-12153526-C-T | not specified | Likely benign (Nov 17, 2022) | ||
3-12153588-A-G | not specified | Uncertain significance (Nov 09, 2023) | ||
3-12153597-A-G | not specified | Uncertain significance (Feb 23, 2023) | ||
3-12153616-C-T | not specified | Uncertain significance (May 24, 2023) | ||
3-12153699-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
3-12154365-T-C | not specified | Uncertain significance (Aug 20, 2023) | ||
3-12154371-T-C | not specified | Uncertain significance (Mar 06, 2023) | ||
3-12154401-C-T | not specified | Uncertain significance (Jun 29, 2023) | ||
3-12154402-G-A | Likely benign (May 21, 2018) | |||
3-12154404-T-C | not specified | Uncertain significance (Oct 12, 2022) | ||
3-12154411-G-C | not specified | Uncertain significance (Nov 30, 2021) | ||
3-12154421-A-C | not specified | Uncertain significance (Feb 22, 2023) | ||
3-12156824-C-G | not specified | Uncertain significance (Jan 04, 2022) | ||
3-12156888-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
3-12157461-C-T | not specified | Uncertain significance (Feb 17, 2022) | ||
3-12158710-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
3-12158716-C-T | not specified | Uncertain significance (Dec 19, 2022) | ||
3-12158719-A-G | not specified | Uncertain significance (Feb 13, 2023) | ||
3-12158728-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
3-12158744-C-T | not specified | Uncertain significance (Aug 21, 2023) | ||
3-12158770-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
3-12158770-G-T | not specified | Uncertain significance (Jul 25, 2023) | ||
3-12158778-C-T | Benign (Dec 31, 2019) | |||
3-12158788-A-G | not specified | Uncertain significance (Oct 12, 2021) | ||
3-12158789-G-C | not specified | Uncertain significance (Dec 06, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TIMP4 | protein_coding | protein_coding | ENST00000287814 | 5 | 6301 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000383 | 0.854 | 125717 | 0 | 31 | 125748 | 0.000123 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.607 | 147 | 128 | 1.15 | 0.00000673 | 1460 |
Missense in Polyphen | 54 | 46.21 | 1.1686 | 587 | ||
Synonymous | -2.21 | 74 | 53.4 | 1.39 | 0.00000294 | 429 |
Loss of Function | 1.30 | 7 | 11.8 | 0.593 | 6.00e-7 | 131 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000707 | 0.000707 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000110 | 0.000105 |
Middle Eastern | 0.000707 | 0.000707 |
South Asian | 0.0000988 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Complexes with metalloproteinases (such as collagenases) and irreversibly inactivates them by binding to their catalytic zinc cofactor. Known to act on MMP-1, MMP-2, MMP-3, MMP-7 and MMP- 9.;
- Pathway
- Matrix Metalloproteinases;Angiogenesis overview;Protein alkylation leading to liver fibrosis;inhibition of matrix metalloproteinases
(Consensus)
Recessive Scores
- pRec
- 0.284
Intolerance Scores
- loftool
- 0.246
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.09
Haploinsufficiency Scores
- pHI
- 0.541
- hipred
- N
- hipred_score
- 0.383
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.731
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Timp4
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- Notch signaling pathway;central nervous system development;biological_process;response to hormone;response to organic substance;negative regulation of endopeptidase activity;response to lipopolysaccharide;response to cytokine;response to drug;ovulation cycle;response to peptide hormone;negative regulation of membrane protein ectodomain proteolysis
- Cellular component
- extracellular space;sarcomere;extracellular matrix
- Molecular function
- protease binding;metalloendopeptidase inhibitor activity;metal ion binding